Investigadores y Productores Farmaceuticos de América (PhRMA)

Obtenga fuente RSS de estos resultados

Noticias y componentes con esta categoría

Ítem
15 October 2014
+ English - Ocultar

Autor(a): CBS 60 Minutes (USA)

"The Cost of Cancer Drugs", 5 Oct 2014...

Leer más

Artículo
10 September 2013
+ English - Ocultar

Autor(a): Sebastian Krueger, Open Society Foundations

Patent protections allow for inflated monopoly pricing and keep generic drugs, which are cheaper, from going to market. Secret international trade deals impose the pharmaceutical companies’ high prices on foreign nations...But Fire in the Blood asks us...

Leer más

Artículo
21 September 2011
+ English - Ocultar

Autor(a): David Brown, Washington Post

Behind...talks at the United Nations and a...document about the need to fight noncommunicable diseases...is a fierce struggle between commercial and health interests...Some of the issues...are the same ones at the heart of...the battle against smoking...

Leer más

Historia
23 February 2009
+ English - Ocultar
Artículo
23 February 2009
+ English - Ocultar

Autor(a): Global Health Progress Initiative

Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today... The United...

Leer más

Artículo
23 February 2009
+ English - Ocultar

Autor(a): United Nations Economic and Social Council (ECOSOC)

Leer más

Artículo
23 June 2007
+ English - Ocultar

Autor(a): Bloomberg

Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na...

Leer más

Artículo
14 February 2007
+ English - Ocultar

Autor(a): Keya Acharya, Inter Press Service

Under the drug regulatory process any drug, whether patented or not, must pass safety, efficacy and quality tests for marketing from the Drug Controller-General of India (DGCI)...the DGCI can [currently] rely on previous test data to approve subsequent...

Leer más

Artículo
3 January 2007
+ English - Ocultar

Autor(a): John Carreyrou, The Wall Street Journal [USA]

In the fall of 2003, Abbott Laboratories...seized on an unusual weapon that helped [its AIDS drug] Kaletra's global sales top $1 billion a year, even as it exposed Abbott to criticism that it was endangering patients. The weapon was an older Abbott...

Leer más

Artículo
31 May 2005
+ English - Ocultar

Autor(a): Alex Berenson, New York Times

When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines...Eli Lilly and some other companies...

Leer más